[go: up one dir, main page]

WO2020091179A3 - Composition de prévention ou de traitement de l'ostéoporose secondaire comprenant un probiotique en tant que principe actif - Google Patents

Composition de prévention ou de traitement de l'ostéoporose secondaire comprenant un probiotique en tant que principe actif Download PDF

Info

Publication number
WO2020091179A3
WO2020091179A3 PCT/KR2019/007317 KR2019007317W WO2020091179A3 WO 2020091179 A3 WO2020091179 A3 WO 2020091179A3 KR 2019007317 W KR2019007317 W KR 2019007317W WO 2020091179 A3 WO2020091179 A3 WO 2020091179A3
Authority
WO
WIPO (PCT)
Prior art keywords
preventing
active ingredient
probiotics
composition
secondary osteoporosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2019/007317
Other languages
English (en)
Korean (ko)
Other versions
WO2020091179A2 (fr
WO2020091179A9 (fr
Inventor
이인옥
박나현
김병국
이철상
김세헌
최인석
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CKD Bio Corp
Korea University Research and Business Foundation
Original Assignee
CKD Bio Corp
Korea University Research and Business Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CKD Bio Corp, Korea University Research and Business Foundation filed Critical CKD Bio Corp
Publication of WO2020091179A2 publication Critical patent/WO2020091179A2/fr
Publication of WO2020091179A3 publication Critical patent/WO2020091179A3/fr
Publication of WO2020091179A9 publication Critical patent/WO2020091179A9/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/143—Fermentum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne une souche A41 de Lactobacillus plantarum avec le numéro d'accès KCTC13686BP, et des compositions pharmaceutiques et alimentaires comprenant, en tant que principe actif, la souche ou une culture de celle-ci. La souche selon la présente invention et sa culture ont un excellent effet dans la prévention, le soulagement ou le traitement de l'ostéoporose, en particulier l'ostéoporose secondaire, et peuvent donc être utilisées utilement dans des compositions alimentaires et pharmaceutiques à cet effet.
PCT/KR2019/007317 2018-10-30 2019-06-18 Composition de prévention ou de traitement de l'ostéoporose secondaire comprenant un probiotique en tant que principe actif Ceased WO2020091179A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180131060A KR102120479B1 (ko) 2018-10-30 2018-10-30 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물
KR10-2018-0131060 2018-10-30

Publications (3)

Publication Number Publication Date
WO2020091179A2 WO2020091179A2 (fr) 2020-05-07
WO2020091179A3 true WO2020091179A3 (fr) 2020-07-23
WO2020091179A9 WO2020091179A9 (fr) 2020-09-03

Family

ID=70463815

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2019/007317 Ceased WO2020091179A2 (fr) 2018-10-30 2019-06-18 Composition de prévention ou de traitement de l'ostéoporose secondaire comprenant un probiotique en tant que principe actif

Country Status (2)

Country Link
KR (1) KR102120479B1 (fr)
WO (1) WO2020091179A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111718873B (zh) * 2020-06-19 2022-09-06 江南大学 一株具有缓解骨质疏松功效的发酵乳杆菌及其应用
CN111621449B (zh) * 2020-07-02 2022-07-12 安徽善和生物科技有限公司 一种益生菌及其在继发性骨质疏松中的应用
WO2023075571A1 (fr) * 2021-11-01 2023-05-04 (주)네오리젠바이오텍 Utilisation de polysaccharides dérivés de souches d'enterococcus genus
CN115806898A (zh) * 2022-08-10 2023-03-17 重庆第二师范学院 一种植物乳杆菌ksfy04及其应用
KR102542996B1 (ko) 2022-11-02 2023-06-14 주식회사 종근당바이오 락토바실러스 퍼멘텀 srk414 균주를 포함하는 인지기능장애 및 알츠하이머병 예방, 개선 또는 치료용 조성물
KR102657370B1 (ko) * 2023-12-08 2024-04-16 주식회사 락토메이슨 대두 단백질 분해능, 아미노산 생성능 개선 효과를 갖는 프로바이오틱스 조성물

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100940125B1 (ko) * 2007-08-24 2010-02-02 국민대학교산학협력단 락토바실러스 카세이에 의한 우유 발효물을 유효성분으로포함하는 골 대사 개선용 조성물
US20110027348A1 (en) * 2007-08-27 2011-02-03 Janos Feher Composition and method inhibiting inflammation
KR101349139B1 (ko) * 2012-02-27 2014-01-10 한국식품연구원 락토바실러스 퍼멘텀 ｌｃ２７２ 균주를 이용한 비타민 ｋ２의 생산 방법 및 이 균주를 이용한 발효유의 제조 방법
JP2015526389A (ja) * 2012-06-04 2015-09-10 バイオガイア・エイビーＢｉｏｇａｉａ ＡＢ 哺乳動物における骨量減少を予防する乳酸菌の選択及び使用
KR20160086249A (ko) * 2015-07-27 2016-07-19 (주) 와이디생명과학 락토바실러스 플란타룸 yd-212 균주 및 이를 이용하여 제조되는 발효물을 포함하는 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014250113B2 (en) * 2013-04-03 2017-03-30 Probi Ab Probiotic strains for use in treatment or prevention of osteoporosis
KR101776613B1 (ko) * 2015-04-22 2017-09-11 주식회사 웰빙엘에스 식물성 유산균을 이용한 유산균 생성물질 제조방법

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100940125B1 (ko) * 2007-08-24 2010-02-02 국민대학교산학협력단 락토바실러스 카세이에 의한 우유 발효물을 유효성분으로포함하는 골 대사 개선용 조성물
US20110027348A1 (en) * 2007-08-27 2011-02-03 Janos Feher Composition and method inhibiting inflammation
KR101349139B1 (ko) * 2012-02-27 2014-01-10 한국식품연구원 락토바실러스 퍼멘텀 ｌｃ２７２ 균주를 이용한 비타민 ｋ２의 생산 방법 및 이 균주를 이용한 발효유의 제조 방법
JP2015526389A (ja) * 2012-06-04 2015-09-10 バイオガイア・エイビーＢｉｏｇａｉａ ＡＢ 哺乳動物における骨量減少を予防する乳酸菌の選択及び使用
KR20160086249A (ko) * 2015-07-27 2016-07-19 (주) 와이디생명과학 락토바실러스 플란타룸 yd-212 균주 및 이를 이용하여 제조되는 발효물을 포함하는 조성물

Also Published As

Publication number Publication date
KR20200050002A (ko) 2020-05-11
KR102120479B1 (ko) 2020-06-09
WO2020091179A2 (fr) 2020-05-07
WO2020091179A9 (fr) 2020-09-03

Similar Documents

Publication Publication Date Title
WO2020091179A3 (fr) Composition de prévention ou de traitement de l'ostéoporose secondaire comprenant un probiotique en tant que principe actif
WO2020091180A3 (fr) Composition pour prévenir ou traiter l'ostéoporose secondaire comprenant des probiotiques en tant que principe actif
IL289610A (en) Bacterial strain Bifidobacterium bifidum, its preparations and related uses
NZ737752A (en) Compositions comprising bacterial strains
EP4086336A4 (fr) Souche de lactobacillus plantarum, et composition pour la prévention ou le traitement des maladies métaboliques la contenant
EP4086334A4 (fr) Souche de lactobacillus fermentum, et composition destinée à prévenir ou à traiter des maladies métaboliques la contenant
WO2018013583A3 (fr) Cocktail de lactobacillus vaginal médicinal
WO2016086210A8 (fr) Compositions probiotiques et prébiotiques et procédés d'utilisation de celles-ci pour le traitement et la prévention de la maladie du greffon contre l'hôte
PT3412766T (pt) Estirpe lactobacillus salivarius, composição que compreende a mesma e suas utilizações
EP4086335A4 (fr) Souche de lactobacillus fermentum, et composition pour la prévention ou le traitement de maladies métaboliques, comprenant celle-ci
WO2018165765A9 (fr) Molécules probiotiques pour réduire la virulence d'agents pathogènes
MX2015014896A (es) Cepas bacterianas que poseen actividad antimicrobiana y composiciones de control biologico que las contienen.
SG10201910740UA (en) Lactobacillus fermentum gkf3, composition comprising the strain and method for improving psychataxia using the same
AU2019263623A8 (en) Probiotic Bifidobacterium breve strain and compositions comprising said strain
WO2016109852A8 (fr) Compositions bactériennes
PH12020551375A1 (en) Lactobacillus plantarum cjlp17 having antiviral and immunomodulatory efficacies and composition comprising the same
PH12017502042A1 (en) Dietary supplement
MX2024008447A (es) Cepas de bacillota con crecimiento mejorado.
PH12018550110B1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
MX2016014991A (es) Composiciones que contienen acido borico y una mezcla de lactobacilos.
AU2016100865A4 (en) Multi-strain probiotic composition
EE201400038A (et) Hüpokolestereemilist ja antimikroobset agenti probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks südame-veresoonkonnahaiguste ja Clostridium difficile põhjustatava kõhulahtisuse ennetamisek
WO2018135843A3 (fr) Souche de lactobacillus fermentum pouvant empêcher la perte de cheveux, favoriser la pousse des cheveux, ou améliorer la fonction sexuelle, et composition comprenant cette souche
WO2015121458A3 (fr) Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149
EP4360625A3 (fr) Traitement prébiotique et probiotique pour réduire la dysbiose buccale et favoriser l'eubiose

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19879898

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19879898

Country of ref document: EP

Kind code of ref document: A2